A pre-clinical quantitative model predicts the pharmacokinetics/pharmacodynamics of an anti-BDCA2 monoclonal antibody in humans.

Biliouris, Konstantinos

A pre-clinical quantitative model predicts the pharmacokinetics/pharmacodynamics of an anti-BDCA2 monoclonal antibody in humans. [electronic resource] - Journal of pharmacokinetics and pharmacodynamics 12 2018 - 817-827 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1573-8744

10.1007/s10928-018-9609-6 doi


Animals
Antibodies, Monoclonal, Humanized--pharmacology
Body Weight
Computer Simulation
Drug Evaluation, Preclinical
Humans
Immunoglobulin G
Lectins, C-Type--antagonists & inhibitors
Lupus Erythematosus, Cutaneous--drug therapy
Lupus Erythematosus, Systemic--drug therapy
Macaca fascicularis
Membrane Glycoproteins--antagonists & inhibitors
Models, Biological
Receptors, Immunologic--antagonists & inhibitors